Hippocampal 5-hydroxytryptamine receptors: abnormalities in postmortem brain from schizophrenic subjects

被引:17
作者
Scarr, E
Pavey, G
Copolov, D
Dean, B
机构
[1] Mental Hlth Res Inst Victoria, Rebecca L Cooper Res Labs, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia
[3] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia
[4] Monash Univ, Dept Psychol Med, Clayton, Vic 3168, Australia
关键词
hippocampus; postmortem; serotonin receptors; schizophrenia; human; CNS;
D O I
10.1016/j.schres.2004.02.007
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
There is strong evidence that hippocampal 5-hydroxytryptamine (5-HT) systems are affected in schizophrenia and hence we have studied a number of markers of the 5-HT system in hippocampi from subjects with schizophrenia. Using in situ radioligand binding with autoradiography we measured [H-3]proplyamino-8-hydroxy- 1,2,3,4-tetrahydronapthalene, [H-3]ketanserin and [H-3]sumatriptan binding in hippocampi from 20 schizophrenic and 20 control subjects. There were significant decreases in the density of [H-3]ketanserin binding to the 5-HT2A receptor (5-HT2AR) in the Cornu Ammonis (CA) 3 (p = 0.006), CA 1 (stratum radiatum p = 0.02; pyramidal layer p = 0.0008) and subiculum (pyramidal layer p = 0.0004), as well as methiothepin-insensitive [H-3]sumatriptan binding to the 5-HTIFR in the CA 1 (p = 0.016), stratum radiatum/lacunosum moleculare (p = 0.04) and subiculum (p = 0.015) from subjects with schizophrenia. Therewereno differences in the densities of 5-HT1AR, 5-HT(1D)Ror 5-HT4R in hippocampi from subjects with schizophrenia. These data support the hypothesis that regionally specific reductions in the density of the 5-HT2AR and 5-HTIFR are a component of the pathological processes underlying schizophrenia. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:383 / 392
页数:10
相关论文
共 38 条
[21]   THE EVOLUTION OF THE SEROTONIN-DOPAMINE ANTAGONIST CONCEPT [J].
HUTTUNEN, M .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (01) :S4-S10
[22]   SEROTONIN UPTAKE SITES AND SEROTONIN RECEPTORS ARE ALTERED IN THE LIMBIC SYSTEM OF SCHIZOPHRENICS [J].
JOYCE, JN ;
SHANE, A ;
LEXOW, N ;
WINOKUR, A ;
CASANOVA, MF ;
KLEINMAN, JE .
NEUROPSYCHOPHARMACOLOGY, 1993, 8 (04) :315-336
[23]   TISSUE PH AS AN INDICATOR OF MESSENGER-RNA PRESERVATION IN HUMAN POSTMORTEM BRAIN [J].
KINGSBURY, AE ;
FOSTER, OJF ;
NISBET, AP ;
CAIRNS, N ;
BRAY, L ;
EVE, DJ ;
LEES, AJ ;
MARSDEN, CD .
MOLECULAR BRAIN RESEARCH, 1995, 28 (02) :311-318
[24]   Co-localization of 5-HT1B/1B/1F receptors and glutamate in trigeminal ganglia in rats [J].
Ma, QP .
NEUROREPORT, 2001, 12 (08) :1589-1591
[25]  
MELTZER HY, 1995, CLIN NEUROSCI, V3, P64
[26]   Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [H-3]paroxetine [J].
Naylor, L ;
Dean, B ;
Opeskin, K ;
Pavey, G ;
Hill, C ;
Keks, N ;
Copolov, D .
JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (06) :749-757
[27]  
Österlund MK, 1999, MOL BRAIN RES, V74, P158
[28]   Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison [J].
Pantelis, C ;
Velakoulis, D ;
McGorry, PD ;
Wood, SJ ;
Suckling, J ;
Phillips, LJ ;
Yung, AR ;
Bullmore, ET ;
Brewer, W ;
Soulsby, B ;
Desmond, P ;
McGuire, PK .
LANCET, 2003, 361 (9354) :281-288
[29]   [H-3]sumatriptan binding sites in human brain: Regional-dependent labelling of 5-HT1D and 5-HT1F receptors [J].
Pascual, J ;
DelArco, C ;
Romon, T ;
DelOlmo, E ;
Pazos, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 295 (2-3) :271-274
[30]   5-HT1B/D receptor antagonists [J].
Pauwels, PJ .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1997, 29 (03) :293-303